Age and CRP Associated With Improved Tissue Pathogen Identification in Children With Blood Culture Negative

Jessica D Burns1, Vidyadhar V Upasani2, Tracey P Bastrom2

  • 1Phoenix Children's Hospital, Phoenix, AZ.

Insights

In children with acute hematogenous osteomyelitis (AHO), age over 3.1 years and C-reactive protein (CRP) above 4.1 mg/dL predict positive tissue cultures when blood cultures are negative. These factors help guide the utility of tissue biopsy in pediatric AHO cases.

Area of Science:

  • Pediatric Infectious Diseases
  • Orthopedic Surgery
  • Clinical Microbiology

Background:

  • Acute hematogenous osteomyelitis (AHO) is a common pediatric condition requiring accurate diagnosis for effective management.
  • Blood and tissue cultures are crucial for pathogen identification in AHO, guiding treatment and reducing failure rates.
  • Current guidelines recommend tissue cultures, especially when blood cultures are negative.

Purpose of the Study:

  • To identify predictors of positive tissue cultures in pediatric patients with AHO when blood cultures yield negative results.
  • To establish criteria for optimizing the diagnostic yield of tissue biopsies in AHO.
  • To inform clinical decision-making regarding the necessity of tissue sampling in pediatric osteomyelitis.

Main Methods:

  • Retrospective comparative study involving 1003 children with AHO across 18 US pediatric medical centers.
  • Analysis of predictors for positive tissue cultures in patients with negative blood cultures.
  • Determination of optimal cutoffs for predictors using sensitivity and specificity analysis.

Main Results:

  • In children with negative blood cultures (n=385), tissue cultures were positive in 69.4%.
  • Multivariate analysis identified age (P <0.001) and C-reactive protein (CRP) (P =0.004) as independent predictors of positive tissue cultures.
  • Age >3.1 years and CRP >4.1 mg/dL demonstrated 87.3% sensitivity for predicting positive tissue cultures in blood culture-negative cases.

Conclusions:

  • Tissue biopsy may offer limited clinical value for AHO patients under 3.1 years with CRP ≤ 4.1 mg/dL, considering procedural morbidity.
  • For AHO patients over 3.1 years with CRP > 4.1 mg/dL, tissue biopsy may be beneficial, though empiric antibiotic coverage can impact results.
  • These findings help refine the indications for tissue biopsy in pediatric AHO, balancing diagnostic utility against invasiveness.
Abstract